3,999
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Preparation of resveratrol dry suspension and its immunomodulatory and anti-inflammatory activity in mice

, , , , , , , ORCID Icon, , , , , , & ORCID Icon show all
Pages 8-15 | Received 29 May 2019, Accepted 25 Nov 2019, Published online: 17 Dec 2019

References

  • Afsar SK, Rajesh Kumar K, Venu Gopal J, Raveesha P. 2013. Assessment of anti-inflammatory activity of Artemisia vulgaris leaves by cotton pellet granuloma method in Wister albino rats. J Pharm Res. 7:463–467.
  • Amri A, Chaumeil J, Sfar S, Charrueau C. 2012. Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release. 158(2):182–193.
  • Bergman M, Levin GS, Hanna B, Djaldetti M, Salman H. 2013. Resveratrol affects the cross talk between immune and colon cancer cells. Biomed Pharmacother. 67(1):43–47.
  • Bertacche V, Lorenzi N, Nava D, Pini E, Sinico C. 2006. Host guest interaction study of resveratrol with natural and modified cyclodextrins. J Incl Phenom Macrocycl Chem. 55(3–4):279–287.
  • Boocock DJ, Faust G, Patel KR, Schinas AM, Brown V, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ. 2007. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidem Biomar. 16(6):1246–1252.
  • Bralley EE, Greenspan P, Hargrove JL, Wicker L, Hartle DK. 2008. Topical anti-inflammatory activity of Polygonum cuspidatum extract in the TPA model of mouse ear inflammation. J Inflamm. 5(1):1.
  • Chen M, Chen XX, Song X, Muhammad A, Jia RY, Zou YF, Yin LZ, Li LX, He CL, Ye G, et al. 2019. The immune-adjuvant activity and the mechanism of resveratrol on Pseudorabies virus vaccine in a mouse model. Int Immunopharmacol. 76:105876.
  • Chinese Pharmacopoeia Commission. 2015. Pharmacopoeia of People’s Republic of China. China: China Medical Science Press.
  • Dong WW, Liu YJ, Lv Z, Mao YF, Wang YW, Zhu XY, Jiang L. 2015. Lung endothelial barrier protection by resveratrol involves inhibition of HMGB1 release and HMGB1-induced mitochondrial oxidative damage via an Nrf2-dependent mechanism. Free Radical Bio Med. 88(part B):404–416.
  • Fan EG, Zhang K, Zhu MZ, Wang Q. 2010. Obtaining resveratrol: from chemical synthesis to biotechnological production. Mini Rev Org Chem. 7(4):272–281.
  • Feng LL, Wu XF, Liu HL, Guo WJ, Luo Q, Tao FF, Ge HM, Shen Y, Tan RX, Xu Q, et al. 2013. Vaticaffinol, a resveratrol tetramer, exerts more preferable immunosuppressive activity than its precursor in vitro and in vivo through multiple aspects against activated T lymphocytes. Toxicol Appl Pharm. 267(2):167–173.
  • Feng YH, Zhou WL, Wu QL, Li XY, Zhao WM, Zou JP. 2002. Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol Sin. 23(10):893–897.
  • Franciosoa A, Mastromarino P, Masci A, d’Erme M, Mosca L. 2014. Chemistry, stability and bioavailability of resveratrol. Med Chem. 10(3):237–245.
  • Fulgenzi A, Bertelli AAE, Magni E, Ferrero E, Ferrero ME. 2001. In vivo inhibition of TNF alpha-induced vascular permeability by resveratrol. Transpl P. 33(3):2341–2343.
  • ImLer TJ, Petro TM. 2009. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+ IL-10+ T cells, CD4− IFN-γ+ cells, and decreased macrophage IL-6 expression. Int Immunopharmacol. 9(1):134–143.
  • Jeong MH, Yang KM, Choi YJ, Kim SD, Yoo YH, Seo SY, Lee SH, Ryu SR, Lee CM, Suh Hs, et al. 2012. Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+ CD25+ regulatory T cells in FM3A tumor bearing mice. Int Immunopharmacol. 14(3):328–333.
  • Jiang L, Fei DS, Gong R, Yang W, Yu W, Pan SH, Zhao MR, Zhao MY. 2016. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury. Inflamm Res. 65(11):905–915.
  • Jin ML, Zhao K, Huang QS, Shang P. 2014. Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int J Biol Macromol. 64:257–266.
  • Kim KO, Park H, Kim HS. 2014. Effects of high-protein diet and/or resveratrol supplementation on the immune response of irradiated rats. Prev Nutr Food Sci. 19(3):156–163.
  • Lai X, Cao M, Song X, Jia RY, Zou YF, Li LX, Liang XX, He CL, Yin LZ, Yue GZ, et al. 2017. Resveratrol promotes recovery of immune function of immunosuppressive mice by activating JNK/NF-κB pathway in splenic lymphocytes. Can J Physiol Pharmacol. 95(6):763–767.
  • Lai X, Pei QS, Song X, Zhou X, Yin ZQ, Jia RY, Zou YF, Li LX, Yue GZ, Liang XX, et al. 2016. The enhancement of immune function and activation of NF-κB by resveratrol-treatment in immunosuppressive mice. Int Immunopharmacol. 33:42–47.
  • Liu KT, Meng ZJ, Li Y, Liu JW, Xu Y, Wang YL, Li XM. 2019. Preparation and evaluation of mosapride citrate dual-release dry suspension. AAPS PharmSciTech. 20(4):1–12.
  • Manayi A, Vazirian M, Saeidnia S. 2015. Echinacea purpurea: pharmacology, phytochemistry and analysis methods. Pharmacogn Rev. 9:63–72.
  • Oh JG, Hwang DJ, Heo TH. 2018. Direct regulation of IL-2 by curcumin. Biochem Biophys Res Co. 495(1):300–305.
  • Park EJ, Pezzuto JM. 2015. The pharmacology of resveratrol in animals and humans. Biochim Biophys Acta. 1852(6):1071–1113.
  • Peng W, Qin RX, Li XL, Zhou H. 2013. Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb. et Zucc.: a review. J Ethnopharmacol. 148(3):729–745.
  • Pervaiz SZ. 2003. Resveratrol: from grapevines to mammalian biology. Faseb J. 17(14):1975–1985.
  • Pezzuto JM. 2008. Grapes and human health: a perspective. J Agric Food Chem. 56(16):6777–6784.
  • Rowe RC. 2012. Handbook of pharmaceutical excipients. Greyslake, IL: Pharmaceutical Press.
  • Schwager J, Richard N, Riegger C, Salem N. 2015. ω-3 PUFAs and resveratrol differently modulate acute and chronic inflammatory processes. BioMed Res Int. 2015:1–11.
  • Svajger U, Jeras M. 2012. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases. Int Rev Immunol. 31:202–222.
  • Wang ZM, Chen YC, Wang DP. 2016. Resveratrol, a natural antioxidant, protects monosodium iodoacetate-induced osteoarthritic pain in rats. Biomed Pharmacother. 83:763–770.
  • Wang GX, Hu ZQ, Fu QT, Song X, Cui QK, Jia RY, Zou YF, He CL, Li LX, Yin ZQ. 2017. Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade. Sci Rep. 7(1):45006.
  • Wang GX, Hu ZQ, Song X, Cui QK, Fu QT, Jia RY, Zou YF, Li LX, Yin ZQ. 2017. Analgesic and anti-inflammatory activities of resveratrol through classic models in mice and rats. Evid-Based Complement Alternat. 2017:1–9.
  • Wang B, Sun J, Li LN, Zheng J, Shi YH, Le GW. 2014. Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice. Food Funct. 5(7):1452–1463.
  • Yeh DYW, Fu YH, Yang YC, Wang JJ. 2014. Resveratrol alleviates lung ischemia and reperfusion–induced pulmonary capillary injury through modulating pulmonary mitochondrial metabolism. Transpl P. 46(4):1131–1134.
  • Yuan JS, Lu LL, Zhang ZL, Zhang SC. 2012. Dietary intake of resveratrol enhances the adaptive immunity of aged rats. Rejuv Res. 15(5):507–515.
  • Zhang LY, Xu CC, Mao JJ, Wang WW, Han H, Pu YQ, Zhang T. 2019. Formulation and characterization of novel dry suspension and dry emulsion of 20(S)-protopanaxadiol. AAPS Pharmscitech. 20(7):275.
  • Zunino SJ, Storms DH. 2009. Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro. J Nutr. 139(8):1603–1608.